BETRF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Aug 12 closing price
Capitalization
9.38M
BIXT
Price
$0.08
Change
-$0.00 (-0.00%)
Updated
Aug 12 closing price
Capitalization
6.91M
Interact to see
Advertisement

BETRF vs BIXT

Header iconBETRF vs BIXT Comparison
Open Charts BETRF vs BIXTBanner chart's image
BETTERLIFE PHARMA
Price$0.06
Change-$0.00 (-0.00%)
Volume$9.2K
Capitalization9.38M
Bioxytran
Price$0.08
Change-$0.00 (-0.00%)
Volume$117.79K
Capitalization6.91M
BETRF vs BIXT Comparison Chart in %
Loading...
BETRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BETRF vs. BIXT commentary
Aug 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BETRF is a Hold and BIXT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 13, 2025
Stock price -- (BETRF: $0.06 vs. BIXT: $0.08)
Brand notoriety: BETRF and BIXT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BETRF: 49% vs. BIXT: 140%
Market capitalization -- BETRF: $9.38M vs. BIXT: $6.91M
BETRF [@Biotechnology] is valued at $9.38M. BIXT’s [@Biotechnology] market capitalization is $6.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $96.01B to $0. The average market capitalization across the [@Biotechnology] industry is $1.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BETRF’s FA Score shows that 0 FA rating(s) are green whileBIXT’s FA Score has 0 green FA rating(s).

  • BETRF’s FA Score: 0 green, 5 red.
  • BIXT’s FA Score: 0 green, 5 red.
According to our system of comparison, BETRF is a better buy in the long-term than BIXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BETRF’s TA Score shows that 4 TA indicator(s) are bullish while BIXT’s TA Score has 5 bullish TA indicator(s).

  • BETRF’s TA Score: 4 bullish, 5 bearish.
  • BIXT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BIXT is a better buy in the short-term than BETRF.

Price Growth

BETRF (@Biotechnology) experienced а -6.56% price change this week, while BIXT (@Biotechnology) price change was -5.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.20%. For the same industry, the average monthly price growth was +21.00%, and the average quarterly price growth was +18.32%.

Industries' Descriptions

@Biotechnology (+8.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BETRF($9.38M) has a higher market cap than BIXT($6.91M). BIXT YTD gains are higher at: -13.682 vs. BETRF (-15.030). BETRF has higher annual earnings (EBITDA): -1.45M vs. BIXT (-2.38M). BETRF has more cash in the bank: 19K vs. BIXT (4.35K). BIXT (1.26M) and BETRF (1.3M) have identical debt. BETRF (0) and BIXT (0) have equivalent revenues.
BETRFBIXTBETRF / BIXT
Capitalization9.38M6.91M136%
EBITDA-1.45M-2.38M61%
Gain YTD-15.030-13.682110%
P/E RatioN/AN/A-
Revenue00-
Total Cash19K4.35K437%
Total Debt1.3M1.26M103%
FUNDAMENTALS RATINGS
BETRF vs BIXT: Fundamental Ratings
BETRF
BIXT
OUTLOOK RATING
1..100
8255
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8564
P/E GROWTH RATING
1..100
39100
SEASONALITY SCORE
1..100
5046

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIXT's Valuation (84) in the null industry is in the same range as BETRF (100). This means that BIXT’s stock grew similarly to BETRF’s over the last 12 months.

BIXT's Profit vs Risk Rating (100) in the null industry is in the same range as BETRF (100). This means that BIXT’s stock grew similarly to BETRF’s over the last 12 months.

BIXT's SMR Rating (100) in the null industry is in the same range as BETRF (100). This means that BIXT’s stock grew similarly to BETRF’s over the last 12 months.

BIXT's Price Growth Rating (64) in the null industry is in the same range as BETRF (85). This means that BIXT’s stock grew similarly to BETRF’s over the last 12 months.

BETRF's P/E Growth Rating (39) in the null industry is somewhat better than the same rating for BIXT (100). This means that BETRF’s stock grew somewhat faster than BIXT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BETRFBIXT
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
58%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 26 days ago
73%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
BETRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTOS5.930.33
+5.89%
Custom Truck One Source
SANM123.844.68
+3.93%
Sanmina Corp
INBK22.920.77
+3.48%
First Internet Bancorp
CSCO71.380.71
+1.00%
Cisco Systems
ABVC2.94-0.01
-0.34%
ABVC BioPharma

BETRF and

Correlation & Price change

A.I.dvisor tells us that BETRF and AVCTF have been poorly correlated (+15% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BETRF and AVCTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BETRF
1D Price
Change %
BETRF100%
-2.86%
AVCTF - BETRF
15%
Poorly correlated
N/A
BSEM - BETRF
3%
Poorly correlated
+2.49%
BPMUF - BETRF
1%
Poorly correlated
N/A
BIXT - BETRF
1%
Poorly correlated
-8.38%
BIESF - BETRF
-2%
Poorly correlated
N/A
More

BIXT and

Correlation & Price change

A.I.dvisor tells us that BIXT and CCCC have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIXT and CCCC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIXT
1D Price
Change %
BIXT100%
-8.38%
CCCC - BIXT
22%
Poorly correlated
-7.44%
IMUX - BIXT
22%
Poorly correlated
+0.38%
WVE - BIXT
20%
Poorly correlated
+4.26%
DOMH - BIXT
20%
Poorly correlated
+25.14%
BSEM - BIXT
11%
Poorly correlated
+2.49%
More